MeiraGTx Holdings (MGTX) Treasury Shares (2017 - 2025)
MeiraGTx Holdings' (MGTX) quarterly Treasury Shares came in at $6.2 million in Q4 2025, up 45.43% YoY from $4.3 million in Q4 2024, and little changed on a QoQ basis from $6.2 million in Q3 2025.
MeiraGTx Holdings (MGTX) Treasury Shares (2017 - 2025) Analysis & Trends
MeiraGTx Holdings (MGTX) has 9 years of Treasury Shares data on file, last reported at $6.2 million in Q4 2025.
- Quarterly Treasury Shares rose 45.43% year-over-year to $6.2 million in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $6.2 million (up 45.43% YoY) and the FY2025 annual result came in at $6.2 million, up 45.43% from the prior year.
- Treasury Shares was little changed at $6.2 million in Q4 2025, from $6.2 million in the prior quarter.
- In the past five years, Treasury Shares ranged from a high of $6.3 million in Q2 2025 to a low of $1.4 million in Q3 2021.
- A 5-year average of $3.4 million and a median of $2.8 million in 2023 frame the typical range for Treasury Shares.
- Annual changes were most pronounced in 2024 — Treasury Shares soared 59.78% — and 2025, when it fell 17.22%.
- Tracing MGTX's Treasury Shares over 5 years: stood at $1.4 million in 2021, then surged by 54.24% to $2.2 million in 2022, then rose by 21.94% to $2.7 million in 2023, then soared by 59.78% to $4.3 million in 2024, then jumped by 45.43% to $6.2 million in 2025.
- The last three Treasury Shares figures came in at $6.2 million (Q4 2025), $6.2 million (Q3 2025), and $6.3 million (Q2 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Treasury Shares (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | 36.40 Mn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | - |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | 5.08 Mn |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | - |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | - |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | 2.72 Mn |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | - |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | 92,219.00 |
| 10 | MeiraGTx Holdings | 1.10 Bn | 1.03 Bn | - | 6.18 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 6.18 Mn |
| Dec 31, 2025 | 6.18 Mn |
| Sep 30, 2025 | 6.18 Mn |
| Sep 30, 2025 | 6.18 Mn |
| Jun 30, 2025 | 6.25 Mn |
| Jun 30, 2025 | 6.25 Mn |
| Mar 31, 2025 | 3.39 Mn |
| Mar 31, 2025 | 3.39 Mn |
| Dec 31, 2024 | 4.25 Mn |
| Dec 31, 2024 | 4.25 Mn |
| Sep 30, 2024 | 4.25 Mn |
| Sep 30, 2024 | 4.25 Mn |
| Jun 30, 2024 | 4.36 Mn |
| Jun 30, 2024 | 4.36 Mn |
| Mar 31, 2024 | 4.09 Mn |
| Mar 31, 2024 | 4.09 Mn |
| Dec 31, 2023 | 2.66 Mn |
| Dec 31, 2023 | 2.66 Mn |
| Sep 30, 2023 | 2.66 Mn |
| Sep 30, 2023 | 2.66 Mn |